CAS 89778 27 8 Toremifene Citrate Powder For Antiestrogen

CAS 89778 27 8 Toremifene Citrate raw Steroid Powder Fareston powder

Toremifene Citrate CAS 89778-27-8

Toremifene Citrate Synonyms: FC 1157a; Fareston; NK 622; NSC 613680

Toremifene Citrate Molecular Formula: C26H28ClNO·C6H8O7
Toremifene Citrate Molecular Weight: 598.09
Toremifene Citrate Melting Point: 158-164 ºC
Toremifene Citrate Boiling Point: 535.1 ºC at 760 mmHg
Toremifene Citrate Density: 1.045g/cm3
Toremifene Citrate Refractive index: 1,416-1,418
Toremifene Citrate Appearance: White or almost white powder
Toremifene Citrate Drug Class: Selective Estrogen Receptor Modulator
Toremifene Citrate Active Life: 5-7 days

Toremifene Citrate Use: An antiestrogen and antineoplastic. Nonsteroidal antiestrogen structurally similar to Tamoxifen.

Toremifene Citrate Descriptions:

Fareston will display both estrogen antagonist / agonist properties in the body. This puts Fareston in the same category as Nolvadex and Clomid, the two most popular drugs in Farestons category. FARESTON is an estrogen agonist/antagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors.

Toremifene administration for a period of 3 months in men with idiopathic oligozoospermia is associated with significant improvements of sperm count, motility, and morphology, mediated by increased gonadotropin secretion and possibly a direct beneficial effect of toremifene on the testes. The above findings are also indicative of a better testicular exocrine (improved sperm parameters) response to treatment in men whose partners achieved pregnancy compared with those who did not. Further randomized, placebo-controlled trials should be conducted to determine whether this particular selective estrogen receptor modulator can be useful as an initial approach in men with oligozoospermia.

Related products:

Contact US